TY  - CHAP
M1  - Book, Section
TI  - Cardiomyopathy and Myocarditis
A1  - Lakdawala, Neal K.
A1  - Stevenson, Lynne Warner
A1  - Loscalzo, Joseph
A2  - Kasper, Dennis
A2  - Fauci, Anthony
A2  - Hauser, Stephen
A2  - Longo, Dan
A2  - Jameson, J. Larry
A2  - Loscalzo, Joseph
PY  - 2014
T2  - Harrison's Principles of Internal Medicine, 19e
AB  - Cardiomyopathy  is  disease  of  the  heart  muscle.  It  is  estimated  that  cardiomyopathy  accounts  for  5–10%  of  the  heart  failure  in  the  5–6  million  patients  carrying  that  diagnosis  in  the  United  States.  This  term  is  intended  to  exclude  cardiac  dysfunction  that  results  from  other  structural  heart  disease,  such  as  coronary  artery  disease,  primary  valve  disease,  or  severe  hypertension;  however,  in  general  usage,  the  phrase  ischemic  cardiomyopathy  is  sometimes  applied  to  describe  diffuse  dysfunction  attributed  to  multivessel  coronary  artery  disease,  and  nonischemic  cardiomyopathy  to  describe  cardiomyopathy  from  other  causes.  As  of  2006,  cardiomyopathies  are  defined  as  “a  heterogeneous  group  of  diseases  of  the  myocardium  associated  with  mechanical  and/or  electrical  dysfunction  that  usually  (but  not  invariably)  exhibit  inappropriate  ventricular  hypertrophy  or  dilatation  and  are  due  to  a  variety  of  causes  that  frequently  are  genetic.”1  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2021/11/27
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1120806030
ER  -